Trulicity is injected under the skin once per week.

Tesamorelin is a small molecule (called a peptide).

When participants who had previously received tesamorelin were instead given placebo, all of the beneficial effects of tesamorelin disappeared.

Tesamorelin is a small molecule (called a peptide).

Theratechnologies scientists discovered EGRIFTA® (tesamorelin for injection) in 1995.

support and educational tools on how to prepare and inject tesamorelin

In clinical trials, tesamorelin was very well tolerated.

Full instructions should be included with each vial of Tesamorelin.

However, the presence of these antibodies did not alter the effectiveness of tesamorelin.

After consideration of the NDS, Health Canada decided that the risks of tesamorelin outweighed its benefits under the proposed conditions of use.

Scientists at Theratechnologies discovered EGRIFTA®(tesamorelin for injection) in 1995.

Given its many improvements over the original version of tesamorelin, EGRIFTA SVTM should help sustain growth for tesamorelin over the coming years.

Tesamorelin (Egrifta) comes to Canada—what you need to know

Tesamorelin is an analog of growth hormone releasing factor (GRF).

After initiating therapy with tesamorelin, the body's ability to respond to insulin may change.